Trends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries

This cross-sectional study evaluates the geographical variation in the availability of photodynamic therapy for the Medicare population in the United States and characterizes the temporal trends of photodynamic therapy cost and use from 2012 to 2017.

Chemotherapy and photodynamic therapy combined in a single drug to fight resistant cancers

Clinicians combat the drug resistances of some cancer types by using a combination of different drugs. To make this approach more effective, chemists have designed a chemical conjugate that can simultaneously attack several cellular targets using different modes of action. Such a single-drug therapy would increase the chances of killing all cancer cells, the authors state in the journal…